Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers Get access Arrow Jul 10, 2025 | Lymphopenia
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer Jul 19, 2023 | Uncategorized
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability Jul 19, 2023 | Uncategorized
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia Jul 19, 2023 | Uncategorized
